Journal Information
Vol. 109. Issue 4.
Pages 296 (May 2018)
Download PDF
More article options
Vol. 109. Issue 4.
Pages 296 (May 2018)
DOI: 10.1016/j.adengl.2018.03.014
Full text access
Risk of Skin Cancer Associated With Narrowband UV-B Phototherapy
Riesgo fotocarcinogénico asociado a la fototerapia ultravioleta B de banda estrecha
J. Aguileraa,b
a Laboratorio de Fotobiología Dermatológica, Centro de Investigaciones Médico-Sanitarias, Universidad de Málaga, Málaga, Spain
b Departamento de Medicina y Dermatología, Facultad de Medicina, Universidad de Málaga, Málaga, Spain
Related content
Actas Dermosifiliogr. 2018;109:340-510.1016/j.adengl.2018.03.009
J.M. Ortiz-Salvador, D. Subiabre-Ferrer, M. Saneleuterio-Temporal, A.M. Victoria Martínez, A. Pérez-Ferriols, J.J. Vilata Corell, V. Alegre de Miquel
Article information
Full Text
Download PDF
Full Text

Phototherapy with ultraviolet radiation is gaining importance in hospital dermatology departments because of its high therapeutic efficacy in various skin diseases and its relatively low cost. Narrowband UV-B phototherapy involves simple exposure of the skin to various doses of a light source that emits electromagnetic radiation at around 311nm. Consequently, cumulative exposure to UV-B could lead to adverse effects on chromophores such as cellular DNA and expose the patient to a risk of photocarcinogenesis in the long term.

In the present study, Ortiz-Salvador et al1 provide a complete retrospective analysis of the potential impact of narrowband UV-B phototherapy on the generation of skin cancer in a series of 474 patients followed for a mean of 5.8 years after cumulative exposure to this type of radiation. Although the results cannot be extrapolated to the general population, the number of patients included and the duration of follow-up point us toward conclusions that are at least locally interesting, namely, application of high-dose narrowband UV-B phototherapy over a specific period does not seem to significantly increase the risk of nonmelanoma skin cancer beyond the normal risk of cumulative actinic damage sustained during an individual's lifetime.

J.M. Ortiz-Salvador, D. Subiabre Ferrer, M. Saneleuterio-Temporal, A.V. Martínez, A. Pérez Ferriols, J.J. Vilata Corell, et al.
Riesgo de fotocarcinogénesis asociado a la fototerapia UVB-BE. Estudio epidemiológico de un hospital terciario.
Actas Dermosifiliogr, 109 (2018), pp. 340-345

Please cite this article as: Aguilera J. Riesgo fotocarcinogénico asociado a la fototerapia ultravioleta B de banda estrecha. Actas Dermosifiliogr. 2018;109:296.

Copyright © 2018. Elsevier España, S.L.U. and AEDV
Actas Dermo-Sifiliográficas (English Edition)

Subscribe to our newsletter

Article options
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?